SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 17th, 2019 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of May 16, 2019 (the “Effective Date”), is by and among TFF Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the investors listed on the Schedule of Buyers, attached hereto as Exhibit A (individually, a “Buyer” and collectively, the “Buyers”).
AMENDMENT #1 TO PATENT LICENSE AGREEMENTPatent License Agreement • July 17th, 2019 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations
This Amendment #1 to the Patent License Agreement (“Amendment”) is made and entered into as of November 30, 2018 (“Amendment Effective Date”) by and between TFF Pharmaceuticals, Inc. (“Licensee”) and The University of Texas at Austin, on behalf of the Board of Regents of the University of Texas System (“Licensor”), an agency of the State of Texas.
January 26, 2018Letter Agreement • July 17th, 2019 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations • California
This letter agreement (the “Agreement”) confirms the terms and conditions pursuant to which Liquid Patent Advisors, LLC (“Consultant”) will provide certain strategic and intellectual property advisory services to TFF Pharmaceuticals, Inc. (together with its subsidiaries and successors, the “Company”) (the “Engagement”).
COMMERCIAL LEASECommercial Lease • July 17th, 2019 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations • Pennsylvania
A portion of the real property known as Suite Number(s) 4 , Lower and First Level Office floor(s) consisting of approximately 1500 square feet and located at 20 E Court St and 2 private parking spaces. Unit(s) 4 Zip 18901 in the municipality of Doylestown Borough County of Bucks, in the Commonwealth of Pennsylvania, with improvements consisting of construction of half wall on first floor (paid by tenant); basement construction to include carpeting and three offices enclosed with dry wall and glass (paid by landlord) __________________________________________________________________________________.
AMENDED AND RESTATED CONSULTING AGREEMENTConsulting Agreement • July 17th, 2019 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
THIS AMENDED AND RESTATED CONSULTING AGREEMENT (the “Agreement”) is made as of the 20th day of December, 2018 (the “Effective Date”), by and between TFF Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on the one hand, and Robert S. Mills (the “Director”) and RSM Consulting, LLC, a Florida limited liability company (“RSM Consulting”), on the other hand.
